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Abstract
The Arabidopsis thaliana Somatic Embryogenesis Receptor Kinases (SERKs) consist of five members, SERK1 to SERK5, of the
leucine-rich repeat receptor-like kinase subfamily II (LRR-RLK II). SERK3 was named BRI1-Associated Receptor Kinase 1 (BAK1)
due to its direct interaction with the brassinosteroid (BR) receptor BRI1 in vivo, while SERK4 has also been designated as
BAK1-Like 1 (BKK1) for its functionally redundant role with BAK1. Here we provide genetic and biochemical evidence to
demonstrate that SERKs are absolutely required for early steps in BR signaling. Overexpression of four of the five SERKs—
SERK1, SERK2, SERK3/BAK1, and SERK4/BKK1—suppressed the phenotypes of an intermediate BRI1 mutant, bri1-5.
Overexpression of the kinase-dead versions of these four genes in the bri1-5 background, on the other hand, resulted in
typical dominant negative phenotypes, resembling those of null BRI1 mutants. We isolated and generated single, double,
triple, and quadruple mutants and analyzed their phenotypes in detail. While the quadruple mutant is embryo-lethal, the
serk1 bak1 bkk1 triple null mutant exhibits an extreme de-etiolated phenotype similar to a null bri1 mutant. While
overexpression of BRI1 can drastically increase hypocotyl growth of wild-type plants, overexpression of BRI1 does not alter
hypocotyl growth of the serk1 bak1 bkk1 triple mutant. Biochemical analysis indicated that the phosphorylation level of BRI1
in serk1 bak1 bkk1 is incapable of sensing exogenously applied BR. As a result, the unphosphorylated level of BES1 has lost
its sensitivity to the BR treatment in the triple mutant, indicating that the BR signaling pathway has been completely
abolished in the triple mutant. These data clearly demonstrate that SERKs are essential to the early events of BR signaling.
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Introduction
Brassinosteroids (BRs) are naturally produced plant hormones
regulating many developmental processes from seed germination
to flowering and senescence [1]. BR deficiency or response
mutants show typical phenotypic defects including decreased rate
of seed germination, rounded and epinastic rosette leaves,
extremely dwarfed stature, delayed flowering time, reduced male
fertility, postponed leaf senescence, and extremely de-etiolated
phenotypes grown under dark conditions [2–5]. Although both
plants and animals use steroids as growth regulators, the signaling
pathways in the two kingdoms are divergent [6]. While animal
steroids are known to be perceived by nuclear receptors which
can directly regulate gene transcription upon ligand binding, BRs
are sensed by a single-pass transmembrane leucine-rich repeat
receptor-like protein kinase (LRR-RLK) named Brassinosteroid
Insensitive 1 (BRI1) and two BRI1 paralogs, BRI1-Like 1 (BRL1)
and BRL3 [3,7–9]. When BR is absent, BRI1 was found to exist as
a homodimer whose cytoplasmic domain interacts with a
membrane-anchored protein termed BRI1 Kinase Inhibitor 1
(BKI1), blocking the interaction between the kinase domains of
BRI1 and its co-receptor BRI1-Associated Receptor Kinase 1
(BAK1) [10–13]. Recent crystal structure analyses demonstrated
that the LRRs of BRI1 form an extremely twisted helical solenoid
structure and the hydrophobic pocket formed by LRRs and the
‘‘island’’ domain provides a direct binding site for BRs [14,15].
The ligand-receptor interaction initiates the BR signaling cascade,
mostly via reversible phosphorylation and dephosphorylation [16].
It was proposed that during early events of BR signaling, the BR
receptor BRI1 and its co-receptor BAK1 follow a reciprocal and
sequential phosphorylation process before downstream compo-
nents can be activated [17]. Interaction of BR with the
extracellular domain of BRI1 triggers a conformational change
of the cytoplasmic domain of BRI1, causing phosphorylation of
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BKI1 on a conserved tyrosine residue, resulting in the dissociation
of phosphorylated BKI1 from BRI1 [12,18]. It is likely that the
BRI1 kinase domain is autophosphorylated and activated via an
intermolecular mechanism, and the activated BRI1 then recruits
BAK1, via a kinase-to-kinase and extracellular domain-to-
extracellular domain double lock mechanism, in close proximity
and phosphorylates several Thr residues within the activation loop
of BAK1, activating the co-receptor [19,20]. The active BAK1
then phosphorylates multiple residues within the juxtamembrane
and carboxyl terminus regions of BRI1, fully activating BRI1 and
creating proper docking sites for association of other BRI1
downstream components such as BR-Signaling Kinases (BSKs)
[21]. The activated BSKs can inhibit kinase activity of a negative
regulator Brassinosteroid Insensitive 2 (BIN2) by activating a
protein phosphatase named bri1 Suppressor 1 (BSU1) to
dephosphorylate a phosphotyrosine residue (pTyr200) on BIN2
[22]. Inactivation of BIN2 causes the accumulation of two
unphosphorylated transcription factors Brassinazole-Resistant 1
(BZR1) and bri1-Ems-Suppressor 1 (BES1) in nuclei, directly
mediating the expression of BR responsive genes [23–28]. Phos-
phorylated forms of BES1 and BZR1, on the other hand, are trapped
in cytoplasm by interacting with 14-3-3 proteins and eventually
degraded via a 26S proteasome-mediated pathway [29–32].
The role of BAK1 has been mainly defined by various gain-of-
function genetic and biochemical analyses [10,11,17,20]. The
significance of the function of BAK1, however, has so far not been
demonstrated by a loss-of-function genetic analysis which is
considered as the most reliable approach to reveal biological
functions of a given gene. A BAK1 null mutant only exhibits a
subtle bri1-like defective phenotype suggesting either additional
homologues of BAK1 play redundant roles with BAK1, or BAK1
and its homologues only provide an enhancing but not an essential
role to BR signaling. The significance of BAK1 and its
homologues in mediating BR signaling should be determined in
a mutant plant with lesions of BAK1 and all its functionally
redundant genes. Recent studies indicated that BAK1 and its
homologues also play important roles in regulating several BR-
independent signaling pathways such as anther development, cell-
death control, and disease resistance [33]. For example, the serk1
serk2 double mutant shows an anther defective phenotype [34,35];
the bak1 bkk1 double null mutant displays light-dependent
spontaneous cell death at the seedling stage [36,37]; and the
bak1 single mutant exhibits uncontrolled cell death and reduced
innate immunity responses to a variety of pathogens [38–42].
These findings add additional complexity to our efforts towards
understanding the significance of BAK1 in BR signaling pathway.
In this study, we show that four out of five members of the
SERK subfamily (SERK1 to SERK4), in the wild-type Arabidopsis
Columbia background (Col-0), may play functionally redundant
roles in BR signaling. In Col-0, SERK5 contains a mutation in an
important amino acid residue which likely abolishes the kinase
activity of SERK5 [36]. We subsequently isolated null mutants for
all four kinase active SERKs, and generated double, triple, and
quadruple mutants using two sets of independent null mutants.
Our detailed analysis indicates that dark grown serk1 bak1 bkk1
triple mutants show a typical de-etiolated phenotype resembling a
null bri1 mutant. Physiological and biochemical analyses indicate
that the triple mutant is insensitive to BR treatment similar to a
null bri1 mutant. Furthermore, the phosphorylation level of BRI1
in the triple mutant is completely unresponsive to BR treatment,
suggesting that BRI1 cannot initiate BR signaling without BAK1
and its homologues. These results provide clear genetic and
biochemical evidence that BAK1 plays an essential role in the BR
signal transduction pathway.
Results
SERK1, SERK2, BAK1, and BKK1 are the only members in
the LRR-RLK II subfamily which can suppress bri1-5 when
overexpressed
BAK1 was previously identified as a coreceptor of BRI1 in
mediating BR signaling [10,11]. Genetic data demonstrating
BAK1 is essential to BR signal transduction is still lacking. If BAK1
plays a role which is as critical as BRI1, a mutant plant with loss-
of-function mutation of BAK1 and all its functionally redundant
genes should exhibit a typical bri1 null mutant phenotype
(Figure 1A). A bak1 null mutant, however, shows a subtle bri1-
like phenotype suggesting that there may be the LRR-RLK II
subfamily genes that are functionally redundant with BAK1. The
five SERKs are grouped in a single clade of the LRR-RLK II
subfamily according to phylogenetic analyses [43,44]. Based on
sequence similarity, it is logical to hypothesize that any BAK1
functionally redundant proteins would be members of the LRR-
RLK II subfamily. To test this hypothesis, all 14 LRR-RLK II
members were overexpressed in the intermediate bri1-5 mutant in
the WS2 background [45]. Our results indicated that only SERK1,
SERK2, BAK1, and BKK1 could partially suppress bri1-5 pheno-
types when overexpressed (Figure 1B). These overexpressed
transgenic plants showed elongated petioles and wild-type like
bolting and flowering time.
Previous studies already indicated in vivo physical interactions of
BRI1 with SERK1, BAK1, and BKK1, respectively [10,11,36,46].
In this study, we tested the in vivo interaction between BRI1 and
SERK2 using transgenic plants overexpressing BRI1-FLAG and
SERK2-GFP. Our result indicated that BRI1-FLAG can weakly
interact with SERK2-GFP in vivo. Unlike the interactions of BRI1
with BAK1 and BKK1, the interaction between BRI1 and
SERK2 cannot be significantly enhanced with exogenously
applied BR (Figure S1), but the phosphorylation of SERK2 can
be dramatically enhanced by the supplementation of BR (Figure
S1). These results suggest that SERK2 may have fewer roles in BR
signaling compared to the other three SERKs, but unnatural
manipulation such as overexpression of SERK2 and exogenous
application of BR can reveal its functions in BR signaling.
Author Summary
Brassinosteroids (BRs) are a group of plant hormones
critical for plant growth and development. BRs are
perceived by a cell-surface receptor complex including
two distinctive receptor kinases, BRI1 and BAK1. Whereas
BRI1 is a true BR-binding receptor, BAK1 does not appear
to have BR-binding activity. Therefore, BAK1 is likely a co-
receptor in BR signal transduction. The genetic significance
of BAK1 was not clearly demonstrated in previous studies
largely due to functional redundancy of BAK1 and its
closely related homologues. It was not clear whether BAK1
plays an essential role or only an enhancing role in BR
signaling. In this study, we identified all possible BAK1
redundant genes in the Arabidopsis thaliana genome and
generated single, double, triple, and quadruple mutants.
Detailed analysis indicated that, without BAK1 and its
functionally redundant proteins, BR signaling is completely
disrupted, largely because BRI1 has lost its ability to
activate downstream components. These studies provide
the first piece of loss-of-functional genetic evidence that
BAK1 is indispensable to the early events of the BR
signaling pathway.
Essential Role of SERKs in BR Signaling
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To further confirm the function of SERKs in BR signaling,
kinase-inactive versions of all 14 LRR-RLK II members were
generated by mutating a conserved lysine residue in the ATP
binding site of each of these genes. These mutated genes were
named mSERK1, mSERK2, mBAK1, mBKK1, etc. All 14 mutated
genes were overexpressed in bri1-5. If mutated mSERKs still can
interact with bri1-5, the resulting transgenic plants should show a
dominant negative phenotype. Our results indicated that most of
the transgenic plants obtained for all the four constructs of mSERKs
showed phenotypes resembling that of a null bri1 mutant, such as
bri1-4 [45] (Figure 1C). These data suggest that SERK1, SERK2,
BAK1, and BKK1 are the only 4 LRR-RLK II genes that are
involved in BR signaling.
serk1 bak1 bkk1 triple null mutant shows null bri1-like
phenotypes in the dark
To better understand the genetic significance of SERKs in BR
signaling, single, double, triple, and quadruple mutants for all four
SERKs were generated. Two independent sets of T-DNA insertion
lines for all the four SERKs were obtained from the Arabidopsis
Biological Resource Center (ABRC) (Figure 2). RT-PCR reactions
were performed to confirm that all the lines used do not express
full-length wild-type mRNAs (Figure S2). Therefore, these lines
are likely null mutants. A novel BRI1 T-DNA insertion line named
bri1-701 was also obtained from ABRC. bri1-701 not only showed
no full-length mRNA expression but also exhibited a phenotype
identical to a typical null bri1 mutant. bri1-701 was therefore used
as a null bri1 control throughout the entire studies. Double serk
mutants were generated by crossing two different serk mutants.
Because serk1 serk2, serk1 bak1, and bak1 bkk1 showed male sterility,
reduced male fertility, and cell death phenotypes respectively, we
had to be strategic about generating triple mutants, as discussed in
materials and methods.
We first phenotypically analyzed the first set of single mutants of
the four SERKs, serk1-8, serk2-1, bak1-4, and bkk1-1 (Figure 2). Only
bak1-4 showed subtle bri1-like phenotypes such as shortened
petioles, reduced rosette size, and reduced height when grown in
the light. When grown in the dark, bak1-4 showed slightly
shortened hypocotyls compared to wild-type seedlings as reported
previously (Figure 3; [10,11]). None of the other SERK mutants
showed any visible defective phenotypes. We then generated
double mutants with the four single mutants. Among all 6 possible
double mutants generated, only serk1-8 bak1-4 showed a weak bri1-
like phenotype which is more severe than the bak1-4 single mutant,
including more compact rosette leaves and more shortened
hypocotyls (Figure 3). As a matter of fact, the hypocotyls of
serk1-8 bak1-4 are only about half of the length of wild-type
(Figure 3B, 3C), which is still significantly taller than the bri1-701
null mutant, suggesting that BR signaling is severely but not
completely disrupted in serk1-8 bak1-4. We confirmed that serk1-8
serk2-1 shows a defective male gametogenesis phenotype; and bak1-
4 bkk1-1 shows seedling lethality phenotypes about two weeks after
germination as previously reported [34–36].
Our priority in these genetic studies was to investigate whether
knocking-out BAK1 and its functionally redundant genes in a single
plant can completely abolish BR signaling pathway and recapit-
ulate a bri1-like phenotype. Because bak1-4 bkk1-1 shows a seedling
Figure 1. SERK1, SERK2, BAK1, BKK1 are the only four genes in
the LRR-RLK II subfamily playing redundant roles in mediating
BR signal transduction. A. Phenotypes of wild-type Arabidopsis
(WS2), an intermediate BRI1 mutant, bri1-5, and a null BRI1 mutant, bri1-
4. B. Overexpression of SERK1, SERK2, BAK1, and BKK1 can partially
suppress the defective phenotypes of bri1-5. Overexpression of SERK5
and other members in LRR-RLK II subfamily can not suppress the bri1-5
phenotypes. C. Overexpression of kinase-inactive mutants, mSERK1
(K330E), mSERK2 (K333E), mBAK1 (K317E), and mBKK1 (K322E) dramat-
ically enhances bri1-5 defective phenotypes. Overexpression of mSERK5
(K303E) and other kinase-inactive mutants in LRR-RLK II subfamily does
not enhance the bri1-5 phenotypes. Representative 18-day-old plants
were photographed.
doi:10.1371/journal.pgen.1002452.g001
Figure 2. Two independent sets of T-DNA insertion null
mutants used in this study. Exons are indicated with filled black
boxes. Lines between boxes represent introns. The insertion sites are
shown with triangles and the T-DNA orientations are indicated with
arrows. The T-DNA insertion mutants labeled with blue were the 1st set
of single null mutants used to create double, triple and quadruple
mutants. The ones labeled with green were the 2nd set of mutants used
to generate double, triple, and quadruple mutants.
doi:10.1371/journal.pgen.1002452.g002
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lethality phenotype due to failure of a light-dependent cell death
control [36], we did not anticipate observing a light-grown null
bri1-like phenotype for the triple or quadruple mutants. Therefore,
the phenotypes of the triple and quadruple mutants were mainly
analyzed within the dark-grown conditions. To our surprise, some
of the serk1-8 serk2-1 bak1-4 triple mutant displayed an embryo-
defective phenotype, and the serk1-8 serk2-1 bak1-4 bkk1-1
quadruple mutant are most likely embryo-lethal (data not shown).
Our attention was drawn to one of the triple mutants, serk1-8 bak1-
4 bkk1-1, because this mutant showed an extreme de-etiolated
phenotype similar to that of bri1-701 including shortened
hypocotyls and opened cotyledons (Figure 3B, 3C).
To further confirm that the triple mutant phenotypes result
from the null mutations of the corresponding SERKs, we generated
double, triple, and quadruple mutants using a different set of single
null mutants, serk1-1, serk2-2, bak1-6, and bkk1-2 (Figure 2). All the
defective phenotypes observed are similar to the mutants
generated by the first set of null alleles (Figure S3). Most
importantly, serk1-1 bak1-6 bkk1-2 also showed a severe bri1-like
de-etiolated phenotype (Figure S3). The phenotypic resemblance
suggests that the BR signaling pathway is abolished in the serk
triple mutant similar to that in the bri1 null mutant.
The phenotypes of SERK mutants can be complemented
by corresponding SERK genes
To verify that the observed phenotypes are caused by the loss-
of-function of the SERK genes, we performed complementation
experiments using native SERK promoters. Because the double,
triple, and quadruple mutants generated from 2 sets of
independent mutants look very similar, we performed the
complementation and all other biochemical experiments using
the mutants generated from the 1st set of single null mutant. We
were never able to clone the BKK1 promoter into these constructs;
therefore, the BAK1 promoter was used to drive the expression of
BKK1. When native promoter-driven SERK1 and BAK1 were
transformed into serk1-8 bak1-4, the double mutant phenotypes
were largely rescued (Figure 4A). When BAK1 promoter driven
BAK1 and BKK1 were transformed into serk1-8 bak1-4 bkk1-1 triple
mutant background, the lethality phenotype of the triple mutant
was also rescued (Figure 4A). When SERK1 promoter driven
SERK1 was introduced into the serk1-8 bak1-4 bkk1-1 background,
no rescued plants were ever obtained because of cell death resulted
from knock-out of BAK1 and BKK1 (data not shown). The
transgenic plants were also grown in the dark to examine whether
they restored the de-etiolated phenotype of the mutant plants.
Indeed, SERK1 and BAK1 restored the mutant phenotypes of serk1-
8 bak1-4 in the dark. BAK1 and BKK1 completely rescued the
mutant phenotypes of serk1-8 bak1-4 bkk1-1 in the dark. The
complementation of SERK1 driven by its own promoter only
partially restored the mutant phenotypes, producing semi-dwarf
hypocotyls (Figure 4B, 4C). The reason why pS1::SERK1 only
partially rescued the hypocotyl phenotype of serk1-8 bak1-4 bkk1-1
is not known. Results from two sets of independent null mutants
and from the complementation experiments clearly indicated that
the defective mutant phenotypes were caused by the null
mutations in the SERKs.
The serk1 bak1 bkk1 triple null mutant is insensitive to BR
treatment
To examine whether the null bri1-like phenotype seen in the
dark grown serk1 bak1 bkk1 triple null mutant was caused by the
disruption of BR signaling, a classic root growth inhibition assay
for BR sensitivity was performed [2]. If SERKs play an essential
role in BR signaling, SERK mutants should show a reduced
response to exogenously applied BR. Plants were grown for 7 days
on half strength MS medium agar plates supplied with or without
Figure 3. Representative loss-of-function mutant phenotypes
of SERKs. A. Representative loss-of-function phenotypes of 20-day-old
SERK mutants in the light. Only bak1-4 shows a subtle bri1-like
phenotype among the single knock-out mutants. The double knock-out
mutant serk1-8 bak1-4 shows phenotypes similar to the bri1 weak allele,
bri1-301; and bak1-4 bkk1-1 shows a seedling-lethality phenotype at the
early developmental stage [36]. The triple knock-out mutant serk1-8
bak1-4 bkk1-1 shows phenotypes similar to the bak1-4 bkk1-1 mutant
plants. B. Representative loss-of-function phenotypes of SERK mutants
grown in the dark for 5 days. The mutant bri1-701, a T-DNA insertion
mutant of BRI1, shows a typical null bri1-like phenotype in the dark with
opened cotyledons, short and swollen hypocotyls. The double knock-
out mutant serk1-8 bak1-4 shows partially de-etiolated phenotypes with
opened cotyledons and semi-dwarfed hypocotyls. The triple knock-out
mutant serk1-8 bak1-4 bkk1-1 shows a de-etiolated phenotype almost
identical to that of the BRI1 null mutant, bri1-701. C. Measurements of
the dark-grown seedlings shown in B. Error bars represent standard
deviation (SD).
doi:10.1371/journal.pgen.1002452.g003
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different concentrations of BR. Wild-type and bak1-4 are sensitive
to the root growth inhibition of different concentrations of 24-
epiBL ranging from 1 to 1000 nM, with bak1 showing slightly
reduced sensitivity (Figure 5A). The root growth of serk1-8 bak1-4
was insensitive to 24-epiBL from 1 to 100 nM, but showed some
sensitivity at 1000 nM. Analyses of hypocotyls also showed
reduced sensitivity of serk1-8 bak1-4 to exogenously applied 24-
epiBL (Figure 5B). The root and hypocotyl growth of bri1-701 and
serk1-8 bak1-4 bkk1-1, however, was completely insensitive to 24-
epiBL at concentrations from 1 to 1000 nM. These results indicate
that the triple mutant plants are insensitive to exogenously applied
BR (Figure 5A, 5B). To confirm that the de-etiolated phenotype
seen in the triple mutant is caused by the disruption of the BR
signaling pathway instead of the general photomorphogenesis
pathways, we used two constitutive photomorphogenesis (COP1)
mutants, cop1-4 and cop1-6, as controls to determine whether they
also show insensitivity to exogenous BR treatment (Figure S4A,
S4B). Our results indicated that although COP1 mutants exhibit a
de-etiolated phenotype, they are sensitive to exogenous BR
treatment.
In Col-0, the expression of CPD is down-regulated by
exogenously applied BR via a negative feedback mechanism.
When BR signaling is disrupted as in bri1 null mutants, however,
the expression of CPD is not responsive to BR treatment [47]. To
further confirm that the BR signaling is blocked in serk1 bak1 bkk1
triple mutant, quantitative RT-PCR experiments were performed
to detect the expression levels of CPD and DWF4 in wild-type and
mutant plants treated with or without BR (Figure 5C, 5D). Similar
to previous reports, the expression level of CPD was decreased to
about 20% of wild-type plants when treated with BR. In bri1-701
null mutant, the expression of CPD was not significantly down-
regulated when treated with BR (Figure 5C). Consistent with its
weak bri1-like phenotype, the expression level of CPD in bak1-4 was
decreased dramatically similar to wild-type upon BR treatment.
However, the double knock-out mutant serk1-8 bak1-4 showed
drastically reduced sensitivity to BR treatment with slightly
decreased CPD expression upon BR treatment. The expression
level of CPD in the BR treated serk1-8 bak1-4 bkk1-1 triple null
mutant was not decreased (Figure 5C). Similar to the CPD
response, the expression level of DWF4 was down-regulated to
about 20% in wild-type plants when BR was applied exogenously.
However, BR treated serk1-8 bak1-4 bkk1-1 mutant showed
dramatically reduced sensitivity to exogenous BR application
similar to the bri1-701 mutant plant (Figure 5D). These data
indicate that the BR signaling pathway in the triple mutant of
SERKs is blocked to the same extent as bri1 null mutants.
Phosphorylation level of BES1 is not responsive to BR in
the serk1 bak1 bkk1 triple null mutant
To biochemically test whether the serk1 bak1 bkk1 triple null
mutant is insensitive to exogenously applied BR, the phosphor-
ylation status of BES1 was investigated with a specific anti-BES1
antibody after the wild-type and triple mutant were treated with or
without 1 mM 24-epiBL (Figure 5E, 5F; Figure S5) [48]. In Col-0
wild-type seedlings without BR treatment, two BES1 bands with
almost equal signal intensity were observed, indicating that both
phosphorylated and unphosphorylated BES1 were present. Upon
Figure 4. The phenotypes of SERK mutants can be comple-
mented by each of the SERKs. A. Rescued mutant phenotypes of 21-
day-old plants in the light. The pS1::SERK1-GFP construct restored the
serk1-8 bak1-4 mutant phenotype to a typical bak1-4 like mutant
phenotype, and the pS3::BAK1-GFP construct restored the serk1-8 bak1-4
mutant phenotype to a wild-type like plant. The pS3::BAK1-GFP and
pS3::BKK1-GFP constructs restored the serk1-8 bak1-4 bkk1-1 mutant
phenotype to almost a wild-type like plant. However, pS1::SERK1-GFP
can not rescue the serk1-8 bak1-4 bkk1-1 phenotype in the light. B.
Rescued mutant phenotypes of 5-day-old seedlings in the dark. The
pS1::SERK1-GFP and pS3::BAK1-GFP constructs restored the serk1-8 bak1-
4 mutant phenotypes. The pS1::SERK1-GFP construct partially restored
the serk1-8 bak1-4 bkk1-1 mutant phenotypes to the bak1-4 bkk1-1
double mutant phenotypes with opened cotyledons and taller
hypocotyls than the triple mutant. The pS3::BAK1-GFP and pS3::BKK1-
GFP constructs restored the serk1-8 bak1-4 bkk1-1 mutant phenotype to
a wild-type like seedling. C. Measurements of the dark-grown seedlings
shown in B. Error bars represent SD.
doi:10.1371/journal.pgen.1002452.g004
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BR treatment, unphosphorylated BES1 in wild-type was increased
dramatically and phosphorylated BES1 disappeared, suggesting
that the BR signaling pathway was activated. In the untreated
seedlings of the weak allele of bri1-301, the amount of
phosphorylated BES1 was slightly higher than that of unpho-
sphorylated BES1. In the BR-treated bri1-301 seedlings, the
Figure 5. serk1-8 bak1-4 bkk1-1 triple null mutant is insensitive to exogenous BR treatment. A, B. Root and hypocotyl growth analyses of
wild-type and mutant plant seedlings grown on medium containing different 24-epiBL concentrations. A. Seven-day-old seedlings grown in the light
for root growth analysis. B. Five-day-old seedlings grown in the dark for hypocotyl growth analysis. The double mutant serk1-8 bak1-4 shows reduced
sensitivity to BR treatment and the triple mutant serk1-8 bak1-4 bkk1-1 is completely insensitive to BR treatment. Error bars represent SD. C, D.
Expression of CPD and DWF4 in serk1-8 bak1-4 bkk1-1 shows responses to exogenously applied BR similarly to the null bri1-701 mutant but differently
to wild-type seedlings. Seven-day-old seedlings were treated with or without 1 mM 24-epiBL. Relative expression level of CPD and DWF4 was
measured by quantitative RT-PCR. The feedback inhibition of CPD in serk1-8 bak1-4 is also reduced. ACTIN2 was used as the reference gene. The used
primers are listed in Table S1. Error bars represent SD (n = 3). E, F. The phosphorylation level of BES1 is not responsive to BR treatment in the serk1-8
bak1-4 bkk1-1 triple null mutant. E. Nine-day-old seedlings of wild-type and mutants grown in the light were treated with 0 or 1 mM 24-epiBL for 4 h.
Total proteins were analyzed by an immuo-blotting assay with a specific anti-BES1 antibody. F. Coomassie blue staining showing equally loaded
proteins between each pair of samples. 2, without 24-epiBL treatment; +, with 24-epiBL treatment. BES1-P, phosphorylated BES1; BES1,
unphosphorylated BES1.
doi:10.1371/journal.pgen.1002452.g005
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amount of unphosphorylated BES1 became greater than phos-
phorylated BES1. However, the untreated null mutant bri1-701
showed higher levels of phosphorylated than unphosphorylated
BES1, and the ratio between the two types of BES1 was not
changed when treated with BR. All single SERK null mutants
showed response to BR in a way similar to that of wild-type plants.
Although serk1-8 bak1-4 showed an enhanced bri1-like phenotype
compared to bak1-4 single mutant (Figure 3), BES1 phosphory-
lation levels in the double mutant still show a wild-type like
response (Figure 5E). A previous report showed that BAK1 and
BKK1 function redundantly in BR signaling [36], which is also
supported by the result from this study that untreated bak1-4 bkk1-
1 seedlings showed predominantly phosphorylated BES1 protein,
suggesting that BR signaling is dramatically impaired in the double
mutant. Upon BR treatment, both phosphorylated and unpho-
sphorylated BES1 were detected although the phosphorylated
BES1 was still dominant, indicating that the BR signaling pathway
was not disrupted completely in bak1-4 bkk1-1. Interestingly, the
serk1-8 bak1-4 bkk1-1 triple null mutant only showed the
phosphorylated BES1 band with or without the exogenous BR
application, suggesting that BR signal transduction was entirely
blocked in the triple mutant. serk2-1 bak1-4 bkk1-1 exhibited a
BES1 phosphorylation response similar to bak1-4 bkk1-1. When
serk1-8 serk2-1 bak1-4 was treated with BR, the amount of
unphosphorylated BES1 increased dramatically (Figure 5E). These
results indicate that serk2 has an undetectable effect on BR
signaling in Arabidopsis seedlings; and BR signaling appears to be
entirely blocked in the serk1 bak1 bkk1 triple null mutant. Similar
results were obtained from the second set of knockouts (Figure S5).
Although BR insensitive mutants showed a de-etiolated pheno-
type, de-etiolated mutants do not always show BR insensitivity.
For example, cop1-4 and cop1-6 showed wild-type like BES1
response to BR treatment (Figure S4C).
Overexpression of BRI1 cannot rescue the de-etiolated
phenotype of the serk1 bak1 bkk1 triple mutant, and the
phosphorylation level of BRI1 in the triple mutant is
unresponsive to BR treatment
It was previously reported that overexpression of BRI1 can
drastically increase hypocotyl growth of wild-type plants [7,20].
To test whether BRI1 is still able to promote hypocotyl growth of
the serk1 bak1 bkk1 triple null mutant, we overexpressed BRI1-GFP
in wild-type and the serk1-8 bak1-4 bkk1-1 respectively. Our results
indicated that overexpression of BRI1-GFP can increase hypocotyl
growth of wild-type plants but has no effect on the triple null
mutants (Figure 6A, 6B, 6C). To understand why BRI1 has lost its
physiological roles in the triple mutant, we next analyzed whether
the phosphorylation levels of BRI1 can respond to exogenously
applied BR. In the wild-type plants, exogenous BR treatment
could significantly increase the phosphorylation levels of BRI1 as
reported (Figure 6D; [17,20]); whereas in the serk1 bak1 bkk1 triple
null mutant, phosphorylation of BRI1 remains at an extremely low
level regardless of BR treatment (Figure 6D). These results suggest
that BR signaling is blocked in the triple mutant most likely
because BRI1 has lost its responsiveness to internal bioactive BRs.
Discussion
The function of BAK1 in mediating BR signaling was
independently identified by using a yeast-two hybrid screen for
Figure 6. Overexpression of BRI1 dramatically increases hypocotyl growth of wild type but does not promote hypocotyl growth of
serk1-8 bak1-4 bkk1-1. A. 35S::BRI1-GFP can not suppress the mutant phenotype of serk1-8 bak1-4 bkk1-1. Five-day-old dark grown seedlings were
photographed. B. Measurements of the dark-grown seedlings shown in A. Error bars represent SD. C. Western hybridization indicates the expressed
BRI-GFP fusion protein in transgenic plants. D. Phosphorylation of BRI1 does not respond to exogenously applied BR in the mutant serk1-8 bak1-4
bkk1-1. The membrane proteins were extracted from seven-day-old light-grown seedlings and immunoprecipitated with an anti-GFP antibody. The
threonine phosphorylation levels of BRI1 were detected with a phosphoThr antibody by immuno-blotting analysis. The immunoprecipitated BRI1-
GFP was immuno-blotted with an anti-GFP antibody to show equal loading. 2BL, samples not treated with 24-epiBL; +BL, samples treated with
100 nM 24-epiBL for 90 min.
doi:10.1371/journal.pgen.1002452.g006
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BRI1 interacting proteins and activation tagging for genetic
suppressors of an intermediate BRI1 mutant, bri1-5 [10,11]. Since
then, numerous data supported the biochemical roles of BAK1 in
regulating early events of BR signal transduction [17,20,49]. The
biological significance of BAK1 in BR signaling, however, has
never been convincingly substantiated due to lack of loss-of-
function genetic evidence. If BAK1 is a key component in BR
signaling, a plant lacking BAK1 and all its functionally redundant
genes should exhibit a phenotype identical to a bri1 null mutant. In
addition, the mutant plant should show no response to BR
treatment in a way similar to what has been revealed for null bri1
mutants. To resolve these questions, we set to identify all genes in
the Arabidopsis genome which might play redundant roles with
BAK1. We overexpressed all 14 genes from the LRR-RLK II
subfamily, to which the 5 SERKs belong, in the bri1-5 background
to evaluate their possible roles in BR signaling. Interestingly, only
SERK1, SERK2, BAK1, and BKK1 can suppress the defective
phenotypes of bri1-5 when overexpressed. None of the other 10
genes showed any bri1-5 suppression phenotypes (Figure 1A, 1B).
We also overexpressed kinase-inactive mutants of all these 14
genes in bri1-5. Consistent with the SERK overexpression results,
only mSERK1, mSERK2, mBAK1, and mBKK1 give a dominant
negative phenotype (Figure 1C). We therefore focused on
generating single, double, tripe, and quadruple mutants of these
four genes in order to estimate the genetic contribution of these
four SERKs to BR signaling. Early studies indicated that bak1 bkk1
double nulls are lethal due to failure of a BR-unrelated light-
dependent cell death control pathway [36,37], therefore we did
not expect to observe that a multiple null mutant plant would
recapitulate the bri1 null mutant phenotype shown under light
grown conditions, such as dark green, round and compact leaves,
and extreme dwarfism [2]. Rather, we anticipated seeing that a
multiple null mutant would express a de-etiolated phenotype
resembling that of a bri1 null mutant if SERKs play a key role in
regulating BR signal transduction.
From our current results, we conclude that BAK1 and its
homologues play an indispensable role in initiating BR signaling
(Figure 7). This conclusion is mainly supported by the following
key observations described in this study. First, the serk1 bak1 bkk1
triple null mutant showed a characteristic de-etiolated phenotype
similar to that of a null bri1 mutant under dark grown conditions
(Figure 3B, Figure S3B). Second, the triple null mutant is
insensitive to BR according to the root growth inhibition analysis
and the hypocotyl growth analysis (Figure 5A, 5B), CPD, DWF4
feedback inhibition analysis (Figure 5C, 5D), and accumulation of
unphosphorylated BES1 assay (Figure 5E, Figure S5). In the triple
null mutant, no unphosphorylated forms of BES1 can be detected,
indicating that the BR signaling pathway has been blocked, at least
under a normal physiological setting; and the unphosphorylated
levels of BES1 cannot be induced by exogenously applied BR, as
shown in wild-type plants and other SERK single mutants
(Figure 5E; Figure S5). Finally, overexpression of BRI1 cannot
alter the growth of the triple null mutant most likely because the
phosphorylation of BRI1 is unresponsive to the fluctuation of the
amount of internal biologically active BR (Figure 6). Together,
these results suggest that the biological function of BRI1 in
regulating plant growth is entirely dependent upon the action of
SERKs.
SERK2 is apparently critical for the earlier development of
embryos, as the development of the serk1 serk2 bak1 bkk1 quadruple
null mutant is completely arrested at an early embryo stage
(unpublished data). No viable quadruple mutant seeds were ever
recovered from these genetic analyses. Therefore, analysis of BR
response in quadruple mutant was impracticable. Evidently,
Figure 7. A current model showing SERKs are indispensable to BR signaling. Left: In wild-type plants, upon perception of BR by the
receptor BRI1 and coreceptor BAK1 or its functionally redundant proteins, the phosphorylation levels of BRI1 respond to BR, triggering downstream
BR signaling cascade, resulting the accumulation of unphosphorylated BES1, and ultimately leading to the expression of BR responsive genes. Right:
In serk1 bak1 bkk1 mutant plants, the phosphorylation levels of BRI1 remain at an almost undetectable basal level and do not alter regardless of
elevated concentrations of BR. As a result, most of the BES1 protein exists as an inactive phosphorylated form, which cannot enter to the nuclei and is
incapable to regulate the expression of BR responsive genes.
doi:10.1371/journal.pgen.1002452.g007
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SERK2 plays no significant role at an early postembryonic
seedling developmental stage; and the interaction between SERK2
and BRI1 is extremely weak compared to that of other SERK
members and BRI1 (Figure S1) [10,36,46]. Exogenous application
of BR cannot increase BRI1/SERK2 interactions (Figure S1).
Under an unnatural condition, SERK2 may show BAK1-like
biochemical properties. For example, seedlings treated with
exogenously applied BR can drastically induce SERK2 phosphor-
ylation (Figure S1); and overexpression of SERK2 can partially
suppress the defective phenotypes of bri1-5 (Figure 1B). Our
genetic and biochemical results, however, clearly indicate that
SERK1, BAK1, and BKK1 are the major players for BR signaling
at the Arabidopsis seedling stage.
It is worth noting that phenotypes of single, double, triple, and
quadruple mutants of SERK1, SERK2, BAK1, and BKK1 were
discussed in a previous research article [50]. In that report, the
authors claimed that serk3 serk4 double mutant showed an early
senescence but not a lethality phenotype. It was also reported that
the serk1 serk3 serk4 triple or serk1 serk2 serk3 serk4 quadruple
mutants did not show any enhanced phenotype over the serk1 serk3
double mutant phenotype. The main cause for the discrepancy of
our observations and the results from that report is that the mutant
allele of BAK1/SERK3 used in their genetic analyses, serk3-1/bak1-
3/SALK_ 034523, is actually a leaky mutant. bak1-3 contains a T-
DNA insertion in the 4th intron of the BAK1 genomic DNA (Figure
S6A). RT-PCR analysis and DNA sequence analysis indicated that
bak1-3 can express a reduced amount of wild-type BAK1 mRNA in
bak1-3 bkk1-1 background, although the transcription level of
BAK1 in bak1-3 single mutant is not detectable (Figure S6B).
Consistent with these observations, bak1-3 single mutant does
exhibit a typical null bak1 mutant phenotype which is indistin-
guishable from bak1-4 (Figure S6C). bak1-3 bkk1-1 double mutant,
however, shows a much reduced early senescence phenotype than
bak1-4 bkk1-1 (Figure S6C). Therefore, bak1-3 is not a true null
mutant of BAK1, especially in the situation when BKK1 is also
knocked out (Figure S6B, [33]). In this study, we performed the
genetic analysis by using two independent sets of confirmed
transcriptional nulls (Figure S2B, S2C). Identical results were
obtained from these two sets of mutant analyses (Figure 3A, 3B;
Figure 5E; Figure S3A, S3B; Figure S5). In addition, the null bri1-
like phenotype seen in the dark-grown serk1 bak1 bkk1 triple mutant
can be complemented with BAK1 or BKK1 driven by the BAK1
promoter, but cannot be rescued by SERK1 with its native
promoter (Figure 4A, 4B). The later result is consistent with our
previous discovery that the bak1 bkk1 double null mutant is a
seedling lethal mutant [36].
Our current observations suggest that SERKs play a critical role
in the early events of BR signaling likely via a reciprocal and
sequential phosphorylation model as proposed previously, with
some modifications [20]. In wild-type plants, BR interacting with
its receptor BRI1 in the extracellular domain triggers a
conformational change within the cytoplasmic domain, leading
to the basal activation of cytoplasmic BRI1 kinase, releasing of the
BKI1 inhibitor, and inducing interaction between BRI1 and
BAK1 or its homologues. The initially activated BRI1 evidently
only can activate SERKs but not other downstream components
such as BSKs. Activation of downstream components by BRI1
requires full activation of BRI1 by BAK1 and its functionally
redundant homologues, most likely as a consequence of trans-
phosphorylation. As a result, unphosphorylated forms of BES1 are
accumulated which can directly regulate BR responsive gene
expression (Figure 7). In a serk1 bak1 bkk1 triple null mutant plant,
on the other hand, BR signaling apparently is entirely blocked
from BRI1 to BES1 due to lack of the involvement of BAK1 and
its functionally redundant proteins (Figure 7). As a consequence,
BES1 accumulates as the phosphorylated form, which is incapable
of mediating the expression of BR-responsive genes. Therefore the
triple null mutant plant exhibits a phenotype similar to a bri1 null
mutant. Both are the outcome of disrupted BR signaling. Although
unphosphorylated BES1 level in both the bri1 and serk1 bak1 bkk1
triple null mutants showed almost an undetectable response to
exogenously applied BR, the bril null mutant showed both
phosphorylated and unphosphorylated BES1 (Figure 5E; Figure
S5), suggesting a BR signal leakage in the bri1 null mutant. This
could be contributed by BRL1 and BRL3, both of which play
partially redundant roles with BRI1 [9,51]. In a previous report, it
was hypothesized that without SERKs, BRI1 has basal kinase
activity towards downstream components [20]. The hypothesis
was based upon several observations from the bak1 bkk1 double
null mutant including that the de-etiolation of the bak1 bkk1 is not
as severe as the bri1 null mutant; overexpression of BRI1 can
significantly increase hypocotyl growth of the bak1 bkk1 double null
mutant; and the phosphorylation levels of BRI1 can still respond
to exogenous BR treatment. From this study, we now propose that
without SERKs, BRI1 does not appear to have basal activities
towards downstream components because the serk1 bak1 bkk1 triple
null shows a bri1 null mutant phenotype; overexpression of BRI1
cannot increase the hypocotyl growth of the triple mutant; and in
the triple null mutant the phosphorylation of BRI1 is completely
unresponsive to BR treatment, hinting that BRI1 also cannot
respond to internal BR levels. The BR signaling appears to be
entirely blocked due to a blocked full BRI1 activation event by
SERKs. In the future, analysis will be conducted to determine why
phosphorylation of BRI1 cannot respond to BR in the absence of
SERKs. The ultimate understanding of the roles of SERKs in
BRI1-mediated signaling may rely on a combination of genetics
and structural biology.
Materials and Methods
Plant materials, growth conditions, and crossing
experiments
Arabidopsis accessions WS2 and Columbia-0 (Col-0) were grown
at 22uC in a long-day condition (16 h of light and 8 h of dark) in a
greenhouse except those for phenotypic analysis in the dark which
were grown in half strength MS agar plates with 1% (w/v) sucrose.
To create knock-out mutants used in this study, T-DNA insertion
lines were obtained from The Arabidopsis Biological Resource
center (ABRC) for serk1-1 (SALK_044330), serk1-8 (SALK_071511),
serk2-1 (SALK_058020), serk2-2 (SAIL_119_G03), bak1-3 (SALK_
034523), bak1-4 (SALK_116202), bak1-6 (SAIL_513_A11), bkk1-1
(SALK_057955), bkk1-2 (SALK_105409), serk5-1 (SALK_089460),
and bri1-701 (SALK_003371).
Reverse transcription-polymerase chain reactions (RT-PCR)
were performed to examine the expression of BRI1 and SERKs in
the used mutants. To amplify the full-length CDS and the flanking
mRNA sequence of the T-DNA insertion site of BRI1 and SERKs,
primer pairs BRI1FL-F/BRI1FL-R, BRI1M-F/BRI1M-R, SERK1F-
F/SERK1F-R, SERK1M-F/SERK1M-R, SERK2F-F/SERK2F-R,
SERK2M-F/SERK2M-R, BAK1F/BAK1R, SERK3M-F/SERK3M-
R, SERK4F-F/SERK4F-R, and SERK4M-F/SERK4M-R were used,
respectively. ACTIN2 was amplified as a control by primers RT-
actin2F and RT-actin2R. All the used primers are listed in Table
S1.
The T-DNA mutant plants were genotyped by PCR. Homo-
zygous single knock-out lines were used to generate double knock-
out mutants. Double knock-out mutants of serk1 serk2, and bak1
bkk1 were obtained by segregating from corresponding mutant
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plants with homozygous insertion for one gene and heterozygous
for the second gene. Triple knock-out mutants were obtained by
crossing fertile pairs serk1+/2 serk2 and serk2 bak1, serk1+/2 serk2 and
serk2 bkk1, serk1 bak1 and bak1+/2 bkk1, serk2 bak1 and bak1+/2 bkk1.
The triple knock-out mutants were segregated from self-pollinated
mutant plants serk1+/2 serk2 bak1, serk1+/2 serk2 bkk1, serk1 bak1+/2
bkk1 and serk2 bak1+/2 bkk1 which contain heterozygous insertion
for one gene and homozygous insertions for two other genes.
DNA cloning and plant transformation
Gateway technology was employed to clone all the coding
sequences of SERK cDNA sequences for overexpression in bri1-5
and complementation experiments in mutants as previously
described [44] using the primers listed in Table S1. The amplified
CDS sequences of SERK genes were introduced into the
destination vector pB35GWF with the help of Gateway technol-
ogy. Site-directed mutagenesis was carried out according to the
manual of the QuickChange Site-directed Mutagenesis Kit
(Stratagene, La Jolla, CA). Entry clones of cloned SERK genes
were used as templates for chain extension with primers listed in
Table S1. The mutated entry clones of SERK genes were used for
in vitro DNA recombination with the destination vector pB35GWF
to create expression constructs for Arabidopsis transformation.
To generate constructs for native promoter-driven expression
of SERKs, promoter sequences of SERKs were PCR amplified
from Arabidopsis genomic DNA and inserted into the pBIB-
BASTA-GWR-GFP vector [44] before the gateway cassette by
using the primers listed in Table S1. The resulting constructs
were named as pSERK1-GWR-GFP, pSERK2-GWR-GFP and
pSERK3-GWR-GFP, respectively. Then the cloned coding se-
quences of SERK genes were transferred into these destination
vectors by in vitro DNA recombination to create expression
constructs of pS1::SERK1-GFP, pS2::SERK2-GFP, pS3::SERK3-
GFP and pS3::SERK4-GFP, respectively.
All the cloned sequences were confirmed by sequencing analysis
and the expression constructs were transferred into appropriate
Arabidopsis plants by the floral dip method [52].
Root and hypocotyl growth analyses
Seeds were surface sterilized and placed on half strength MS
plates with 0.8% (w/v) agar, 1% (w/v) sucrose and different
concentrations of 24-epiBL (Sigma, St. Louis, MO). The plates
were cold treated at 4uC for 2 days to ensure uniform germination.
Seeds were considered to begin germination after the plates were
kept at 22uC for 24 hr. The root length was measured seven days
after germination in the light and the hypocotyl length was
measured five days after germination in the dark.
Membrane protein isolation, coimmunoprecipitation,
and Western analysis
Seven-day-old seedlings of transgenic plants with 35S::BRI1-
GFP and 11-day-old liquid-cultured seedlings of transgenic plants
harboring 35S::SERK2-GFP and 35S::BRI1-FLAG were treated
with or without 24-epiBL for 90 min, respectively, and ground to
fine powder in liquid N2 [17]. Membrane protein isolation was
performed as previously described [10]. BRI1-FLAG was
immunoprecipitated from solubilized membrane protein with
agarose-linked a-FLAG antibody (Sigma, St. Louis, MO).
SERK2-GFP and BRI1-GFP were immunoprecipitated with a-
GFP antibody (Invitrogen, Carlsbad, CA) and protein G beads
(Roche, Indianapolis, IN). The immunoprecipitated proteins were
separated on 7.5% SDS polyacrylamide gel for Western analyses
with a-GFP, a-FLAG, a-phosphothreonine antibodies as previ-
ously described [10]. Arabidopsis seedlings grown on half strength
MS plates were harvested and treated with or without 1 mM 24-
epiBL for 4 hr and the total protein was extracted and separated
on 12% SDS polyacrylamide gel to detect the phosphorylation
status of BES1 with an anti-BES1 antibody. Horseradish
peroxidase-linked anti-rabbit or anti-mouse antibodies were used
as secondary antibodies and the signal was detected by Western
Lightning Chemiluminescence Reagent Plus (Perkin-Elmer, Wal-
tham, MA).
Supporting Information
Figure S1 SERK2 shows a basal level of interaction with BRI1.
Co-immunoprecipitation result indicates that SERK2 can interact
with BRI1 at a minimal level. The interaction cannot be enhanced
by the exogenously applied BR. The phosphorylation of SERK2,
on the other hand, is elevated to BR treatment.
(TIF)
Figure S2 BRI1 and SERK mutants used in these studies do not
express full-length mRNA. A. Expression of BRI1 in bri1-701
plants. RT-PCR reactions were performed to detect the full-length
CDS (upper) and the mRNA sequence flanking the T-DNA
insertion site (middle) in the wild type and the bir1-701 mutant.
The primer pairs used are indicated at the right. ACTIN2 was
amplified as a control (Lower). B, C. Expression of SERKs in serk
mutant plants. The full-length CDS sequences and the mRNA
sequences flanking T-DNA insertion sites were amplified with
primer pairs listed in Table S1. The mutants are indicated on the
top.
(TIF)
Figure S3 Representative loss-of-function mutant phenotypes of
the mutants generated by an independent set of T-DNA insertion
null mutants of SERKs. A. Representative loss-of-function
phenotypes of 28-day-old SERK mutants in the light. Only bak1-
6 shows weak bri1-like phenotypes among the single knock-out
mutants with smaller rosette size. The double knock-out mutant
serk1-1 bak1-6 shows similar phenotypes as the bri1 weak allele bri1-
301, and bak1-6 bkk1-2 shows a seedling-lethality phenotype at the
early developmental stage. The triple knock-out mutant serk1-1
bak1-6 bkk1-2 shows similar seedling lethality phenotypes as the
bak1-6 bkk1-2 mutant plants. B. Representative loss-of-function
phenotypes of 5-day-old SERK mutants in the dark. bri1-701 shows
a typical null bri1 phenotype in the dark with opened cotyledons,
shortened and swollen hypocotyls. Double null mutant serk1-1
bak1-6 shows a similar phenotype to the bri1-701, with longer
hypocotyls. The triple knock-out mutant serk1-1 bak1-6 bkk1-2
shows similar phenotypes to the bri1-701, with completely opened
cotyledons, shortened and swollen hypocotyls. C. Measurements
of the dark-grown seedlings shown in B. Error bars represent SD.
(TIF)
Figure S4 The BR signaling pathway is not affected in the
constitutive photomorphogenesis mutant cop1. A. Constitutive
photomorphogenesis of 5-day-old cop1 grown in the dark. B. cop1
mutant plants are sensitive to exogenous BR treatment. The root
length was measured for seven-day-old wild-type and mutant
plants grown on 1/2 MS plates with 0 nM, 1 nM, 10 nM,
100 nM and 1000 nM of 24-epiBL, respectively. Error bars
represent SD. C. BES1 phosphorylation level is responsive to
exogenous BR treatment in cop1 mutant plants similar to that in
wild-type plants. Seven-day-old seedlings of wild-type and mutants
grown in the light were treated with (+) or without (2) 1 mM 24-
epiBL for 4 h. Total proteins were analyzed by Western
hybridization with a specific anti-BES1 antibody. BES1 response
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upon BR treatment in the cop1 mutants is similar to that of wild-
type plants. Coomassie blue staining shows each pair of samples
were equally loaded (Lower panel).
(TIF)
Figure S5 BES1 phosphorylation levels are not responsive to BR
in the triple mutant serk1-1 bak1-6 bkk1-2 generated by the 2nd
independent set of T-DNA insertion lines. A. Seven-day-old
seedlings of wild-type and mutants grown in the light were treated
with 0 or 1 mM 24-epiBL for 4 h. Total proteins were analyzed by
Western hybridization with a specific anti-BES1 antibody. BES1
response upon BR treatment in the triple mutant serk1-1 bak1-6
bkk1-2 is blocked. B. Coomassie blue staining of PAGE-separated
proteins to show equally loaded proteins between each pair of
treated and untreated samples. BL, BR treatment. 2, without BR
treatment; +, with BR treatment. BES1-P, phosphorylated BES1;
BES1, unphosphorylated BES1.
(TIF)
Figure S6 bak1-3 is a leaky T-DNA insertion mutant in bak1-3
bkk1-1 background, whereas bak1-4 is likely a null mutant. A. T-
DNA insertion sites for bak1-3 and bak1-4. Filled boxes represent
exons, lines between boxes represent introns. The positions of the
used primers are shown with arrows and the sequences are listed in
Table S1. F: BAK1F; R: BAK1R; F1: BAK1F1; R1: BAK1R1;
F2: BAK1F2; R2: BAK1R2. B. RT-PCR analyses indicated that
bak1-3 is a leaky mutant in bkk1-1 background. In bak1-3 bkk1-1
double but not in bak1-3 single mutant background, wild-type
BAK1 cDNA can still be detected by RT-PCR. But there is no
wild-type like full-length BAK1 cDNA can be detected by RT-PCR
in bak1-4 single or bak1-4 bkk1-1 double mutants. The used primer
pairs are shown at the right. C. Phenotypes of 19-day-old wild-
type, bak1-3, bak1-4, bak1-3 bkk1-1, and bak1-4 bkk1-1. bak1-3 single
mutant shows phenotypic defects similar to bak1-4; whereas bak1-3
bkk1-1 double mutant shows a much milder phenotype than bak1-4
bkk1-1.
(TIF)
Table S1 Primers used for gene cloning, mutagenesis, real-time
RT–PCR, and RT–PCR.
(DOC)
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